Figure 6.
Ex vivo analysis of F4-IL12 treated tumor-bearing mice. (a) Analysis of tumor-infiltrating lymphocytes in CT26-CEA (left) and C51-CEA (right). Tumors were removed 48 hours after the third injection and analyzed by immunofluorescence staining. Markers specific for CD4+ T cells (CD4), CD8+ T cells (CD8), Natural killer cells (NKp46), and regulatory T cells (Foxp3) were used (green). Vasculature was visualized through CD31 staining (red) and nuclei with DAPI (blue). 20× magnification; scale bar = 100 μm. (b) Phenotype analysis of CD4+ and CD8+ T cells in the tumor of treated C51-CEA bearing mice. Tumors were removed 48 hours after the third injection. Bar plots show expression levels of IFNγ, PD-1 (both in CD4+ and CD8+ T cells), the ratio of CD4+ and CD8+ T cells, and expression of Perforin and Granzyme B in CD8+ T cells. Statistical differences were assessed between mice receiving saline, KSF-IL12, and F4-IL12. *p < 0.05; **p < 0.01 (regular one-way ANOVA test with Tuckey posttest). Error bars = SEM; n = 3.